This webinar was presented on Wednesday, May 16, 2012 by Dr. Helen Smith. Dr. Smith discusses Toxicogenomics.

This webinar was presented on Monday, March 12, 2012 by Dr. Jennifer Cocohoba. Dr. Cocohoba discusses select pharmacogenomic effects on HIV therapy.

Director, PharmGenEd™ Training for Health Professional Schools, Dr. Kelly Lee, Pharm.D, BCPP, discusses how to implement the PharmGenEd™ Train-the Trainer Program into the curriculum, in addition to discussing the evaluation components for faculty trainers.

This webinar was presented on Tuesday, November 2, 2010 by Dr. Alice Gardner. Dr. Gardner discusses select pharmacogenomic effects in patients with asthma.

This webinar was presented on Thursday, October 21, 2010 by Dr. Vicki Ellingrod. Dr. Ellingrod discusses select pharmacogenomic effects in patients treated with antidepressant medications.

This webinar was presented on Tuesday, October 12, 2010 by Dr. Louis Garrison and Dr. David Veenstra. Dr. Garrison and Dr. Veenstra discuss economic issues relating to pharmacogenomics.

Director, PharmGenEd™ Training for Healthcare Practitioners, Joseph Ma, PharmD focuses on content material for Pharmacogenomics Principles and Concepts (Module I) and Clinical Applications of Pharmacogenomics (Module II), in addition to discussing program logistics and implementation. Part 2 of 2 is the Question and Answer session regarding Train-the-Trainer for Healthcare Practitioners.

This webinar was presented on Tuesday, September 21, 2010 by Dr. Jaekyu Shin and Dr. Larisa Cavallari. Dr. Shin and Dr. Cavallari discuss select pharmacogenomic effects of warfarin and statins.

This webinar was presented on Thursday, September 23, 2010 by Dr. Larisa Cavallari and Dr. Jaekyu Shin. Dr. Cavallari and Dr. Shin discuss select pharmacogenomic effects of clopidogrel and beta blockers.

Part 1 of 2 is the content section where Director, PharmGenEd™ Training for Healthcare Practitioners, Joseph Ma, PharmD focuses on content material for Pharmacogenomics Principles and Concepts (Module I) and Clinical Applications of Pharmacogenomics (Module II), in addition to discussing program logistics and implementation.